Catherine Sazdanoff

Catherine Sazdanoff has had an extensive and diverse work experience spanning several industries. Catherine is currently working at Strata Oncology, where they hold the positions of Chief Business Development Officer and Chief Compliance and Legal Officer since February 2021. Prior to this, they served as a Strategy Advisor and the Chief Compliance and Legal Officer from February 2020 to February 2021 at the same company. From September 2017 to January 2020, they worked as a Business Advisor at Strata Oncology. During May 2016 to September 2017, they served as the Chief Business Officer at the company.

In addition to their role at Strata Oncology, Catherine Sazdanoff is an Independent Director at Vascugen since August 2021. Catherine is also the CEO and President of Sazdanoff Consulting LLC since January 2015, where they hold a leadership position.

Catherine Sazdanoff has held positions as an Independent Director at Meridian Bioscience Inc. from August 2015 to February 2023. Catherine served as an Independent Director at InMed Pharmaceuticals from July 2019 to February 2022.

Catherine has also worked as a Lecturer at The University of Chicago Graham School from April 2018 to December 2021. Additionally, they served as an Advisory Board Member at Neurocern, Inc. from April 2016 to December 2020.

Catherine Sazdanoff's extensive experience in the pharmaceutical industry includes various roles at Takeda Pharmaceuticals. Catherine worked as the VP, Head of Corporate Projects from October 2012 to January 2015. Catherine concurrently held the position of Vice President, Global Business Development from July 2011 to May 2013, where they led the global transactions team for R&D licensing, M&A, and strategic alliances. Catherine also worked as Vice President, Corporate Development from December 2010 to June 2011, leading global M&A/strategic alliance activity. Prior to this, they served as the VP, Global Licensing from May 2008 to November 2010, leading transactions team for global M&A/strategic alliances, late-stage in-licensing, and partnering of Takeda assets. Catherine started at Takeda Pharmaceuticals as a Senior Director, Business Development from December 2006 to April 2008, focusing on global strategy development and execution for the oncology therapeutic area.

Before joining Takeda Pharmaceuticals, Catherine Sazdanoff worked for Abbott Laboratories for over 22 years, starting as a Litigation Associate at Isham, Lincoln & Beale from May 1981 to March 1984. Catherine later moved to Abbott Laboratories, where they held positions of increasing responsibility in business development, legal, compliance, and marketing from April 1984 to October 2006. At Abbott, they played a leading role in various areas such as acquisitions, pharmaceutical life cycle strategies, defense litigation, and the implementation of compliance programs.

Overall, Catherine Sazdanoff excels in business development, compliance, legal, and strategic roles, with a strong presence in the pharmaceutical industry.

Catherine Sazdanoff's education history includes a Bachelor's degree in English Language and Literature/Letters from the University of Notre Dame. Catherine also has a Juris Doctor degree from Northwestern University Pritzker School of Law. No specific years of enrollment or completion were provided for either of their degrees.